The Mechanism of Adverse Pregnancy Outcomes Influenced by Maternal Air Pollution Exposure
The Effects of Maternal Exposure to Air Pollution During Pregnancy on Adverse Pregnancy Outcomes Mediated by Inflammatory Cytokine and Hormone
1 other identifier
observational
288
1 country
1
Brief Summary
This research evaluates the effects of maternal exposure to air pollution during pregnancy on adverse pregnancy outcomes, the general demographic information, the level of maternal exposure to air pollution, pregnancy-related information, the occurrence of adverse pregnancy outcomes, and serum indicators of pregnant women during pregnancy are collected. Finally, the research explores that whether the inflammatory cytokine and hormone can mediate the occurrence of adverse pregnancy outcomes under the maternal exposure to air pollution during pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2019
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedFirst Posted
Study publicly available on registry
January 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedApril 29, 2022
August 1, 2021
3.5 years
December 25, 2019
April 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The occurrence of adverse pregnancy outcomes or delivery
Adverse pregnancy outcomes including abortion, gestational diabetes mellitus (GDM), hypertensive disorder complicating pregnancy, preterm birth, birth defects and low birth weight(LBW).
①For abortion, up to 24 weeks. ②For participants without abortion will be assessed when hypertension disorders of pregnancy and GDM occur, then assessment of preterm birth, LBW and birth defects will be conducted when delivery, up to about 9 months
Study Arms (1)
The level of maternal air pollution exposure during pregnancy
The groups will be decided according to the level of maternal exposure to air pollution during pregnancy. Participants will be divided into experimental group (high level of maternal air pollution exposure) and control group (low level of maternal air pollution exposure) or other groups according to research and actual demand.
Interventions
The intervention measure is the level of air pollution, it is a non-human interventional measure based on the weighted average of various air pollutants monitored by air pollution monitoring stations during different period of pregnancy.
Eligibility Criteria
The study participants are healthy pregnant women within 6 weeks of pregnancy from the First Affiliated Hospital of Xi'an Jiaotong University, who meet the inclusion and exclusion criteria, and sign the informed consent before the implementation of this research. All the participants will be followed up about 9 months and measured the serum concentration of inflammatory cytokine and hormone.
You may qualify if:
- The Pregnant women within 6 weeks of gestation from the First Affiliated Hospital of Xi'an Jiaotong University;
- This pregnancy is natural conception, the last menstrual period is definite and the menstrual cycle is basically regular;
- The pregnant examinations are performed in our hospital;
- The pregnant women volunteer to participate in this study and sign the informed consent.
You may not qualify if:
- The couples have chromosomal abnormalities or hereditary diseases;
- The pregnant women have trophoblastic diseases such as hydatidiform mole;
- The pregnant women with genital malformations, such as mediastinal uterus, single-horned uterus, double uterus, etc;
- The pregnant women are definitively diagnosed with uterine fibroids, ovarian cysts, polycystic ovary syndrome, gynecological inflammation and other gynecological diseases;
- The pregnant women are definitively diagnosed with hypertensive, diabetes and other chronic disease before pregnancy;
- The pregnant women are definitively diagnosed with autoimmune diseases such as systemic lupus erythematosus, multiple arteriolar inflammation, rheumatoid arthritis, etc;
- The participants have other serious diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710000, China
Biospecimen
The venous blood from pregnant women is acquired in different time point for measurement of serum concentration of inflammatory cytokine and hormone.
Study Officials
- STUDY DIRECTOR
Wenfang Yang, PHD
First Affiliated Hospital Xi'an Jiaotong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 25, 2019
First Posted
January 2, 2020
Study Start
January 1, 2020
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
April 29, 2022
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share